Two Sigma Securities’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
Other funds holding PHIO
VCM
VFT
HF
SRL
XT
Two Sigma Securities's PHIO Position: Q1 2026 in Review
Two Sigma Securities opened a new position in Phio Pharmaceuticals (PHIO) in Q1 2026: 15,224 shares worth $18.6K. The stake represents ﹤0.01% of the portfolio and ranks #1381 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PHIO as recently as Q2 2024.
Two Sigma Securities first reported a position in PHIO in Q1 2017 and has held it in 15 quarters since. The position peaked at $39K in Q2 2021. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.
- Two Sigma Securities held 15,224 shares of Phio Pharmaceuticals worth $18.6K as of Q1 2026.
- Phio Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
- Phio Pharmaceuticals made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1381 holding.
- Two Sigma Securities first reported a position in Phio Pharmaceuticals in Q1 2017 and has held it in 15 quarters since.
- Two Sigma Securities's Phio Pharmaceuticals position peaked at $39K in Q2 2021.
- 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.